CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a targeted drug delivery system for non-small cell lung cancer using engineered exosomes. By conjugating exosomes with specific peptides and loading them with therapeutic agents, it aims to improve treatment efficacy and patient outcomes.
ABSTRACT:
Lung cancer is the principal cause of cancer-related death around the world and has become more predominant among former than current smokers.
Smoking, alcoholism, air pollution, occupational exposure are among the main causes of non-small cell lung cancer (NSCLCs).
It is difficult to simultaneously deliver therapeutics and nucleic acid to the target site.
With the advancement of nanotechnology, a delivery system composing of cellular proteins which can bypass the reticuloendothelial s…
PERCUROS BV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
